Introduction
Colorectal cancer is a prevalent malignancy in the western world. It accounts for 20 000 deaths in the UK per year (Toft and Arends, 1998) and is the second most common cause of death from cancer in the US (Boring et al., 1994) . Dietary factors, especially heterocyclic amines present in cooked meat, have been implicated in the etiology of colon cancer in humans (Felton et al., 1997; Gooderham et al., 1997) . Among the food-borne carcinogens, 2-amino-1-methyl-6-phenolimidazo [4,5-b] pyridine (PhIP) is one of the most abundant heterocyclic amines. PhIP induces colon tumors in male rats, induces predominantly mammary tumors in female F344 rats , and aberrant crypt foci (ACF), a pre-neoplastic lesion in the colon of rats as well as in mice (Takahashi et al., 1991; Tudek et al., 1989; Sorensen et al., 1997) . PhIP has been shown to be a potent colon mutagen in mice and rats; it induces signi®cantly elevated mutation frequency and a characteristic mutational spectrum (Okonogi et al., 1997a,b) .
Genetic defects have been suspected to be involved in colorectal cancer for several decades (Lynch et al., 1985) . In recent years, hereditary non-polyposis colorectal cancer (HNPCC) has been attributed to a de®ciency in DNA mismatch repair genes, mainly the Msh2 and Mlh1 (Fishel et al., 1994; Bronner et al., 1994; Leach et al., 1993) . A de®ciency in mismatch repair function has also been implicated in the pathogenesis of sporadic colorectal cancers (Fornasarig et al., 2000) . When Msh2 nullizygous mice were treated with the DNA methylating agent N-methyl-N-nitrosourea (MNU), hypermutability was detected in small intestine and thymus (Andrew et al., 1998) , but no increased mutability was detected in heterozygous mice. Recently, Glaab et al. (2000) addressed the cytotoxic and mutagenic response and mutational speci®city in human cancer cell lines defective in Msh2, Mlh1 and Msh6 genes after PhIP treatment (Glaab and Skopek, 1999) . It is not known at present whether Msh2 de®ciency confers an increased susceptibility when exposed to speci®c colon mutagens or carcinogens in mammals. Meanwhile, it is important to determine whether a population with germline or somatic mutations in DNA mismatch repair genes is at increased risk of developing colon cancers when exposed to dietary colonic carcinogens.
Mice harboring the Eschericia coli lacI gene have been used as a mammalian mutation assay for several years (Andrew et al., 1996; de Boer and Glickman, 1998; Dycaico et al., 1994) . In this study we used Msh2/lacI double transgenic mice carrying a dierent functional status of the Msh2 gene as well as the lacI mutational reporter gene. The role of the Msh2 gene in mutagenesis could thus be evaluated by determining mutations in the bacterial lacI gene (Andrew et al., 1998) . respectively), however, due to its large variation, this increase is not signi®cantly dierent.
Results
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Discussion
The Msh2 gene is one of several genes involved in human DNA mismatch repair (Modrich, 1997; Marra and Boland, 1996; Eshleman and Markowitz, 1996) . Its product forms a heterodimer with Msh3 or Msh6 (Acharya et al., 1996; Marsischky et al., 1996) . The Msh2 protein plays an important role in the recognition of various mismatched base pairs and initiates the mismatch repair process (Fishel and Wilson, 1997) . A de®ciency in this gene has been identi®ed as an important genetic factor involved in the pathogenesis (Fishel et al., 1994; Fornasarig et al., 2000; Godard et al., 1999) . As one of the most abundant and most potent heterocyclic amines in our daily diet, PhIP has been recognized as a possible human colonic mutagen and carcinogen Felton et al., 1986; Stuart et al., 2000) . It is important to address whether genetic defects in a population result in an increased susceptibility to tumorigenesis when individuals are exposed to dietary and other environmental carcinogens. The current study addressed whether a mismatch repair de®ciency causes hypermutability in mammals when exposed to a food-borne mutagen. 75 in Msh2 nullizygous mice, a 3 ± 5-fold higher increase compared to that found in the wild type and heterozygous mice. If this environmentally imposed factor causes the same level of increased mutation frequency in the ®ve genes required for colorectal tumorigenesis (Fearon and Vogelstein, 1990) , and the increased mutation frequency does relate to tumorigenesis as proposed by Loeb (1991) , then the Msh2 nullizygous de®ciency will confer a 3 5 ± 5 5 or 243 to 3125 times increase in risk compared to Msh2 pro®cient and heterozygous mice when exposed to PhIP at concentrations used in this study.
PhIP induced mutagenicity is mainly caused by the bulky adduct N 2 -(2'-deoxyguanosin-8-yl)-PhIP (dG-C8-PhIP) (Frandsen et al., 1992) . This C8 modi®ed guanine mispairs with adenine resulting in G:C4T:A transversions (Carothers et al., 1994 ). In the current study, PhIP induced a signi®cant increase in the frequency of G:C4T:A transversions in wild type mice, consistent with previous reports (Endo et al., 1994; Glaab et al., 2000) . In addition, our study shows that the frequency of G:C4A:T transitions also signi®cantly increased after PhIP treatment.
A characteristic mutation recovered in rodents after PhIP treatment is 71 frameshifts found at G:C base pairs (Stuart et al., 2000; Zhang et al., 1996) . In Msh2 +/+ mice, a total of 17 independent 71 frameshifts were identi®ed after PhIP treatment (Table 5) , 16 of which occurred at G:C base pairs. In the control group, ®ve 71 frameshift mutations were recovered with only two occurring at G:C base pairs. The portion of 71 frameshifts occurring at G:C base pairs is signi®cantly higher than at A:T base pairs after PhIP treatment (P=0.023). In Msh2 heterozygous mice, the portion of 71 G:C base pair frameshifts after PhIP treatment is lower than in the Msh2 +/+ PhIP treatment group. However, PhIP increases the frequency of 71 frameshifts occurring at G:C base pairs, from 4/14 in the control group, to 5/8 in the treatment group, although this increase is marginally signi®cant (P=0.059). In the Msh2
group, the distribution of 71 frameshifts occurring at G:C base pairs and A:T base pairs is similar before and after PhIP treatment (12/25 and 12/28 in the control and treatment group respectively) ( Table 5) . One possible explanation of the dierence between Msh2 +/+ and Msh2 7/7 mice is that the Msh2 protein repairs mainly insertion/deletion loops formed by adenine or thymine. Therefore, in Msh2 de®cient mice, the 71 frameshifts spectrum is a combination of the result of both Msh2 gene de®ciency (resulting in A:T site frameshifts) and PhIP induced frameshifts (at G:C base pairs).
An important issue in understanding HNPCC and other sporadic colorectal tumors is whether carriers of DNA mismatch repair genes have an increased risk of developing cancers. In the current study, the heterozygous mice did not display an elevated frequency of G:C4A:T transitions or G:C4T:A transversions compared to the wild type group. However, if we compare the frequency of 71 frameshifts in Msh2 wild type mice and Msh2 heterozygous mice after PhIP treatment (Tables 2 and 3, Figure 2 ), the MF in Msh2 +/7 mice is signi®cantly higher than in the Msh2 +/+ mice (P=0.025). It is important to note, however, that the spontaneous frequency of 71 frameshifts in Msh2 +/7 mice is already eightfold higher than in the Msh2 +/+ mice (0.8610 75 vs 0.1610
75
). If we use the induced MF, which eliminates the background frequency, to compare the eect of PhIP in these two genotypes of mice, the induced frequency of 71 frameshifts is still twofold higher in heterozygous mice than in wild type mice (1.4+0.3610 75 vs 0.7+0.2610
). Recently, Planck et al. (2000) reported that somatic frameshift mutations in mononucleotide repeats have been found in the coding regions of several genes involved in growth control, apoptosis and DNA repair in HNPCC families. The prevalence of Figure 1 The induced mutation frequency of G:C4A:T, G:C4T:A and 71 frameshifts in three genotypes of mice (error bars indicate the standard error of mean) frameshifts mutation in various HNPCC populations suggests the importance of this kind of mutation in the pathogenesis of HNPCC.
We note that the spontaneous mutation frequency in Msh2 7/7 mice is even higher than the MF in Msh2 pro®cient and heterozygous mice after PhIP treatment. An Msh2 de®cient cell line also displayed a high MF compared to the wild type cell line (Glaab and Skopek, 1999) . This may indicate that a de®ciency of the Msh2 gene itself could impose a signi®cant mutational burden to the organism. When de®cient organisms are exposed to environmental mutagenic compounds, such as PhIP, these two factors synergistically aect mutagenesis in the colon.
As shown in Table 4 , the mutational spectrum of Msh2
mice displayed a large elevation of the frequency of G:C4A:T transitions, consistent with a high repair eciency of G:T mispairs by Muta (Msh2/ Msh6) in eukaryotes (Kolodner and Marsischky, 1999) . However, the frequency of other classes of mutation also increased from 2 ± 8-fold compared to wild type mice. It was demonstrated (Radman et al., 1985) in E. coli that among eight base-base mismatches, only C-C is resistant to methyl-directed mismatch repair. G-T, A-C, A-A and G-G mismatches could be repaired eciently, while other mismatches including T-T, T-C or A-G are corrected with poor to good eciency depending on the sequence context (Dohet et al., 1986) . Short insertion-deletion loops are also good substrates for mismatch repair (Modrich, 1991) . In mammalian cells, Muta also displayed a wide range of mispair binding abilities, including all eight base-base mismatches and single nucleotide insertion/deletion mismatches (Acharya et al., 1996) . To a lesser extent, Mutb (Msh2/ Msh3) could repair of 2 ± 8 nucleotides loops (Acharya et al., 1996; Genschel et al., 1998; Kolodner and Marsischky, 1999) . Interestingly, some CT dinucleotide deletions (13 among 239 mutants) at a CTCTCT sequence repeat (position 947/952) were found in Msh2 7/7 mice, but not in wild type and Msh2
mice. This is consistent with the repair speci®city of the Mutb complex. It could thus be inferred that the defect in the Msh2 gene, a major player in mismatch repair, will induce a wide range of mutations. This may account for the elevation of mutation frequencies in other classes of mutations in addition to G:C4A:T transitions in this study.
In vivo mutation frequencies and mutational speci®city in the colon of Msh2 wild type, heterozygous, and nullizygous mice have been determined in this study. Msh2 nullizygous mice have a higher induced mutational frequency after treatment with PhIP Compared to wild type mice, the Msh2 +/7 mice demonstrated an increased frequency of 71 frameshifts in both spontaneous and PhIP treatment groups. Based on the prevalence of 71 frameshifts in HNPCC tumors, the current results suggest that the Msh2 carriers are possibly at an increased risk of developing cancers after PhIP exposure. This may provide an animal model for study of pathogenesis and prevention of HNPCC.
Materials and methods
The Msh2/lacI double transgenic mice were kindly provided by Dr Frank R Jirik (University of British Columbia, Vancouver, BC, Canada). These mice are a cross between the BC-1/lacI transgenic and Msh2 +/7 mice (Andrew et al., 1996) . According to the commonly used protocol for the lacI transgenic assay, three to ®ve mice were assigned to each group. At the age of 8 ± 12 weeks, mice from the Msh2
and Msh2 7/7 group were treated intraperitoneally (i.p) with PhIP (Toronto Research Chemicals, Toronto, ON, Canada) at a dose of 50 mg/kg, once a week for 4 consecutive weeks. PhIP was dissolved in an equal amount of dimethyl sulfoxide (DMSO) (SigmaAldrich) and 0.9% NaCl solution. The mice in control groups were injected with vehicle only. Based on the ®nding that the same metabolites of PhIP are formed in mice treated by i.p or per oral (p.o) (Turteltaub et al., 1989) and that the administered dose could be more precisely managed by i.p than p.o., we chose intraperitoneal injection as the route of exposure.
Twelve weeks after the last treatment, the mice were sacri®ced by carbon dioxide inhalation and cervical dislocation. Colons were removed, rinsed with phosphatebuered saline (PBS),¯ash frozen in liquid nitrogen and stored at 7808C. Genomic DNA was isolated by a dialysis puri®cation procedure (Suri et al., 1996) . LacI transgenes were recovered from puri®ed mice chromosomal DNA by in vitro l packaging (Stratagene, La Jolla, CA, USA). Packaged phage were plated on an SCS-8 bacterial lawn in the presence of 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal). Mutant phage appeared as blue plaques, while the wild type phage were colorless plaques (Rogers et al., 1995). Mutants were picked and puri®ed by re-plating at low density. A 1.5 kb lacI-containing fragment was ampli®ed by PCR (Er¯e et al., 1996) and the mutation spectrum was obtained by direct sequencing using LICOR automatic DNA sequencer (Lincoln, NE, USA). Mutation frequency is calculated as the ratio of total number of independent mutants and total number of plaques screened.
MF data were analysed using COCHARM (created by Troy Johnson, Procter & Gamble, Cincinnati, OH, USA), a computer program that executes the General CochranArmitage test (Cariello and Gorelick, 1996) . Fisher's exact test was used for the comparison of mutational changes, and the Boferonni correction was used when comparing data of more than two groups. Mutation frequencies are given with standard error of mean (s.e.m.).
